# Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study

Study · id `cardio:ct-nct07314775` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07314775](<https://clinicaltrials.gov/study/NCT07314775>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07314775

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 422 participants.

## Technical summary

Registry record NCT07314775. Randomized; double masking; primary purpose treatment. Start 2026-01 (anticipated); primary completion 2028-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 422 participants (planned count; ClinicalTrials.gov record NCT07314775, source copy `cardio:ctgov-nct07314775-2026-01-02`, retrieved 2026-10-31)
- Planned start: 2026-01 (anticipated) (ClinicalTrials.gov record NCT07314775, source copy `cardio:ctgov-nct07314775-2026-01-02`, retrieved 2026-10-31)
- Primary completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT07314775, source copy `cardio:ctgov-nct07314775-2026-01-02`, retrieved 2026-10-31)
- Completion: 2029-01 (anticipated) (ClinicalTrials.gov record NCT07314775, source copy `cardio:ctgov-nct07314775-2026-01-02`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07314775-2026-01-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study
- Condition: Dyslipidemia
- Condition: Carotid Atherosclerotic Plaques
- Intervention (Drug): Yangxin Dawayimixike Honey Paste
- Intervention (Drug): Yangxin Dawayimixike Honey Paste placebo
- Lead sponsor: Xinjiang Uygur Pharmaceutical Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)

## Provenance

Content hash: ac7a1b3ce98a0ee91eccfb69ef05e71ddb64de66ccc739329f50c70bb66a44d7
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
